Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

British Journal of Haematology - ResearchHub

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

X

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Journal

British Journal of Haematology

0007-1048 · Wiley

13 verified public works

Browse all journals →

Outcome heterogeneity in CALR ‐mutated myeloproliferative neoplasms

2026 · 0 citations

The missing link in NET regulation after splenectomy: Splenic control on neutrophil signalling in β‐thalassaemia/ HbE

2026 · 0 citations

Is bridging or slow ramp‐up necessary in patients with high tumour load prior to epcoritamab?

2026 · 0 citations

Massive carcinocythaemia during fulminant relapse of invasive lobular breast carcinoma

2026 · 0 citations

KMT2A amplification marks TP53 ‐altered, complex‐karyotype malignant clones in haematological malignancies

2026 · 0 citations

Warm autoimmune haemolytic anaemia in Taiwan: A population‐based study of epidemiology, treatment patterns, survival and healthcare utilisation (2017–2022)

2026 · 0 citations

Is shortening of corticosteroid duration feasible in paediatric warm autoimmune haemolytic anaemia? A single‐centre experience over 15 years

2026 · 0 citations

Clinical outcome and infectious complications in genetic and suspected genetic neutropenia: A report from the Canadian Inherited Marrow Failure Registry

2026 · 0 citations

Autologous haematopoietic stem cell transplant consolidation and survival outcomes in primary central nervous system lymphoma: Evidence from the National Cancer Database

2026 · 0 citations

Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification—Insights from chromosome count and cytogenetic abnormalities

2026 · 0 citations

Outcomes for post‐transplant relapsed acute lymphoblastic leukaemia in the era of novel therapies: A retrospective multicentre UK study

2026 · 0 citations

Maternal iron status in pregnancy: The liver as an understudied confounder

2026 · 0 citations

A phase IIa study of the anti‐ PD ‐ L1 antibody avelumab in relapsed/refractory PTCL : The AVAIL ‐T trial

2026 · 0 citations

Page 1 of 1